BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18241206)

  • 1. Cytomorphology of urothelial carcinomatous peritoneal effusion.
    Xiao GQ
    Cytopathology; 2008 Apr; 19(2):131-3. PubMed ID: 18241206
    [No Abstract]   [Full Text] [Related]  

  • 2. CD138-positive plasmacytoid urothelial carcinoma of the bladder.
    Patriarca C; Di Pasquale M; Giunta P; Bergamaschi F
    Int J Surg Pathol; 2008 Apr; 16(2):215-7. PubMed ID: 18417684
    [No Abstract]   [Full Text] [Related]  

  • 3. High-grade urothelial carcinoma of the urinary bladder showing acquisition of microcystic histology in the penile metastasis: histogenetic considerations.
    Barresi V; Ieni A; Magno C; Barresi G
    Pathol Res Pract; 2009; 205(8):568-71. PubMed ID: 19179016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Leroy X; Gonzalez S; Zini L; Aubert S
    Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
    Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
    Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
    Sibony M; Billerey C
    Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comment on: immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Papatsoris A; Deliveliotis C
    Eur Urol; 2008 May; 53(5):1073. PubMed ID: 17980953
    [No Abstract]   [Full Text] [Related]  

  • 9. Significantly increased accuracy of urothelial carcinoma detection in destained urine slides with combined analysis of standard cytology and CK-20 immunostaing.
    Soyuer I; Tokat F; Tasdemir A
    Acta Cytol; 2009; 53(3):357-60. PubMed ID: 19534284
    [No Abstract]   [Full Text] [Related]  

  • 10. [An unusual variant of urothelial carcinoma: the "nested variant of urothelial carcinoma." Report of two cases].
    Badoual C; Bergemer-Fouquet AM; Renjard L; Lefrancq T; Lesourd B; Belhiba H; Fetissof F; Vieillefond A
    Ann Pathol; 1999 Apr; 19(2):119-23. PubMed ID: 10349476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A diagnostic pitfall in the pathology of bladder tumors: the nested variant of urothelial carcinoma].
    Auriault ML; Comoz F; Bottet P; Bensadoun H
    Ann Pathol; 2000 Sep; 20(4):400-1. PubMed ID: 11015669
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathologic anatomy of superficial tumors of the bladder].
    Billerey C; Sibony M; Gattegno B; Chopin D
    Prog Urol; 2001 Nov; 11(5):805-63. PubMed ID: 11769082
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
    Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bladder tumor histo-seminar - case 4: Urinary cytology. Atypical urothelial cells of undetermined significance (AUC-US) or "atypical urothelial cells" (AUC of the Paris classification)].
    Piaton E
    Ann Pathol; 2016 Dec; 36(6):386-389. PubMed ID: 27838081
    [No Abstract]   [Full Text] [Related]  

  • 15. [New information in the classification of urothelial tumors of the bladder].
    Guillou L
    Ann Pathol; 1999; 19(5 Suppl):S103-7. PubMed ID: 10599468
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
    Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
    Billerey C; Vieillefond A
    Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
    [No Abstract]   [Full Text] [Related]  

  • 19. Polyomavirus infection and urothelial carcinoma.
    Loghavi S; Bose S
    Diagn Cytopathol; 2011 Jul; 39(7):531-5. PubMed ID: 20891007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas.
    Feil G; Wechsel HW; Nelde HJ; Bichler KH
    Anticancer Res; 1999; 19(4A):2591-7. PubMed ID: 10470200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.